Anantaa Gsk Ifamine Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 1 Year 10 Months
About Anantaa Gsk Ifamine
Anantaa Gsk Ifamine Private Limited (AGIPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 March 2023 (One year and ten months 16 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Professional Services Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Hemant Sharma and Arti Sharma serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U74101DL2023PTC411119
- Company No.
411119
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Mar 2023
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Anantaa Gsk Ifamine?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemant Sharma  | Director | 16-Mar-2023 | Current |
| Arti Sharma | Director | 16-Mar-2023 | Current |
Financial Performance of Anantaa Gsk Ifamine.
Enhance accessibility to Anantaa Gsk Ifamine's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Anantaa Gsk Ifamine?
Unlock access to Anantaa Gsk Ifamine's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Anantaa Gsk Innovations Private LimitedHemant Sharma and Arti Sharma are mutual person
Anantaa Gsk Infraconect Private LimitedHemant Sharma and Arti Sharma are mutual person
- Anantaa Gsk Itradexpert Private Limited
Hemant Sharma and Arti Sharma are mutual person
- Anantaa Gsk Itechnology Private Limited
Hemant Sharma and Arti Sharma are mutual person
- Anantaa Gsk Iedusupport Private Limited
Hemant Sharma and Arti Sharma are mutual person
- Renal Care Division Private Limited
Hemant Sharma is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Anantaa Gsk Ifamine?
Unlock and access historical data on people associated with Anantaa Gsk Ifamine, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anantaa Gsk Ifamine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anantaa Gsk Ifamine's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.